1999
DOI: 10.1093/oxfordjournals.jbchem.a022272
|View full text |Cite
|
Sign up to set email alerts
|

Promotion of Tyrosinase Folding in Cos 7 Cells by Calnexin

Abstract: To understand the process of expression of tyrosinase, a key enzyme of melanogenesis, we examined its maturation in the endoplasmic reticulum (ER) by using a heterogeneous expression system. When human tyrosinase cDNA was introduced into COS 7 cells, tyrosinase activity was minimally detected. Immunofluorescence study revealed that tyrosinase was immunolocalized in the nuclear rim, the reticular network, and the punctuated structures. Because a cytoplasmic tail of tyrosinase-gene family protein functions as a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
60
0

Year Published

1999
1999
2006
2006

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(63 citation statements)
references
References 0 publications
3
60
0
Order By: Relevance
“…For example, if glycosylation is prevented or if glucosidases are inhibited, complexes are not detected between CNX or CRT and the ␣ and ␤ subunits of the T cell receptor (51), influenza hemagglutinin (2), vesicular stomatitis virus G glycoprotein (52), ribonuclease B (35), myeloperoxidase (9), cruzipain (53), and tyrosinase (13). However, complexes can readily be detected at normal or reduced levels under conditions of deglycosylation or glucosidase inhibition with the ⑀ and ␦ subunits of the T cell receptor (20,25), P glycoprotein (23), erythrocyte AE1 (54), acid phosphatase (27), major histocompatibility complex class II-␣ and -␤ chains (19), major histocompatibility complex class II invariant chain (24), major histocompatibility complex class I H chain (this study), and human immunodeficiency virus gp160 (10).…”
Section: Calnexin Associates With Many Substrate Proteins When the Fomentioning
confidence: 99%
“…For example, if glycosylation is prevented or if glucosidases are inhibited, complexes are not detected between CNX or CRT and the ␣ and ␤ subunits of the T cell receptor (51), influenza hemagglutinin (2), vesicular stomatitis virus G glycoprotein (52), ribonuclease B (35), myeloperoxidase (9), cruzipain (53), and tyrosinase (13). However, complexes can readily be detected at normal or reduced levels under conditions of deglycosylation or glucosidase inhibition with the ⑀ and ␦ subunits of the T cell receptor (20,25), P glycoprotein (23), erythrocyte AE1 (54), acid phosphatase (27), major histocompatibility complex class II-␣ and -␤ chains (19), major histocompatibility complex class II invariant chain (24), major histocompatibility complex class I H chain (this study), and human immunodeficiency virus gp160 (10).…”
Section: Calnexin Associates With Many Substrate Proteins When the Fomentioning
confidence: 99%
“…Tyrp1 in humans (36) and in mice (44) is synthesized as a precursor polypeptide of approximately 55-69 kDa in the endoplasmic reticulum (ER). This nascent polypeptide undergoes rapid post-translation folding via di-sulfide bonds into its initial native conformation assisted by molecular chaperones like calnexin, a lectin chaperone, and BiP, the immunoglobulin heavy chain binding protein (both of which are resident ER chaperones) (45,46). Formation of disulfide bonds during the folding of Tyrp1 is crucial for its transport through both secretory pathways in the ER and its subsequent processing/maturation in the Golgi apparatus.…”
Section: Tyrp1 the Proteinmentioning
confidence: 99%
“…Endoplasmic reticulum (ER) processing of Tyr requires the presence of the chaperone calnexin, which is thought to increase ER retention time for Tyr Toyofuku et al, 1999). The most common Tyr mutations are associated with ER retention of the protein, presumably the result of misfolding (Berson et al, 2000;Halaban et al, 2000b;Toyofuku et al, 2001).…”
Section: Introductionmentioning
confidence: 99%